BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10660140)

  • 21. Mechanism of chronic obstructive uropathy: increased expression of apoptosis-promoting molecules.
    Choi YJ; Baranowska-Daca E; Nguyen V; Koji T; Ballantyne CM; Sheikh-Hamad D; Suki WN; Truong LD
    Kidney Int; 2000 Oct; 58(4):1481-91. PubMed ID: 11012883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fas-resistance in ATL cell lines not associated with HTLV-I or FAP-1 production.
    Yamada Y; Sugahara K; Tsuruda K; Nohda K; Hata T; Maeda T; Honda M; Tawara M; Hayashibara T; Joh T; Tomonaga M; Miyazaki Y; Kamihira S
    Cancer Lett; 1999 Dec; 147(1-2):215-9. PubMed ID: 10660109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FAP-1: a protein tyrosine phosphatase that associates with Fas.
    Sato T; Irie S; Kitada S; Reed JC
    Science; 1995 Apr; 268(5209):411-5. PubMed ID: 7536343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemical Localization of Fas-associated phosphatase-1 (FAP-1) in Alzheimer disease hippocampus.
    Savaskan E; Ravid R; Meier F; Müller-Spahn F; Jockers R
    Appl Immunohistochem Mol Morphol; 2005 Jun; 13(2):190-3. PubMed ID: 15894934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells.
    Zhou YW; Komada Y; Inaba H; Azuma E; Sakurai M
    Cell Immunol; 1998 Jun; 186(2):103-10. PubMed ID: 9665752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human pancreatic adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis.
    Ungefroren H; Voss M; Jansen M; Roeder C; Henne-Bruns D; Kremer B; Kalthoff H
    Cancer Res; 1998 Apr; 58(8):1741-9. PubMed ID: 9563493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Both HPV and carcinogen contribute to the development of resistance to apoptosis during oral carcinogenesis.
    Itakura M; Mori S; Park NH; Bonavida B
    Int J Oncol; 2000 Mar; 16(3):591-7. PubMed ID: 10675494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protein-tyrosine phosphatase PTPL1/FAP-1 triggers apoptosis in human breast cancer cells.
    Bompard G; Puech C; Prébois C; Vignon F; Freiss G
    J Biol Chem; 2002 Dec; 277(49):47861-9. PubMed ID: 12354757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Development of anti cancer drugs targeted on Fas-mediated apoptosis signal].
    Takahashi M; Kataoka S
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):222-8. PubMed ID: 9030235
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytokine associated sensitivity of colon carcinoma cells to FasR-mediated cytotoxicity of CTL.
    Chen J; Zhang H; Su F; Min J; Zhang J; Song E
    Asian J Surg; 2002 Jan; 25(1):89-97. PubMed ID: 17585452
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of two Fas-associated phosphatase-1 (FAP-1) promoters in human cancer cells.
    Irie S; Li Y; Kanki H; Ohyama T; Deaven LL; Somlo S; Sato TA
    DNA Seq; 2001; 11(6):519-26. PubMed ID: 11696979
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).
    Umansky V; Ushmorov A; Ratter F; Chlichlia K; Bucur M; Lichtenauer A; Rocha M
    Int J Oncol; 2000 Jan; 16(1):109-17. PubMed ID: 10601555
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural modification of Fas C-terminal tripeptide and its effects on the inhibitory activity of Fas/FAP-1 binding.
    Sawa E; Takahashi M; Kamishohara M; Tazunoki T; Kimura K; Arai M; Miyazaki T; Kataoka S; Nishitoba T
    J Med Chem; 1999 Aug; 42(17):3289-99. PubMed ID: 10464015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fas signaling pathway is functional in colon carcinoma cells and induces apoptosis.
    Houghton JA; Harwood FG; Gibson AA; Tillman DM
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2205-9. PubMed ID: 9815616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.
    Lee SH; Shin MS; Lee HS; Bae JH; Lee HK; Kim HS; Kim SY; Jang JJ; Joo M; Kang YK; Park WS; Park JY; Oh RR; Han SY; Lee JH; Kim SH; Lee JY; Yoo NJ
    Hum Pathol; 2001 Mar; 32(3):250-6. PubMed ID: 11274632
    [TBL] [Abstract][Full Text] [Related]  

  • 36. mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines.
    Komada Y; Inaba H; Zhou YW; Zhang XL; Tanaka S; Azuma E; Sakurai M
    Br J Haematol; 1997 Nov; 99(2):325-30. PubMed ID: 9375749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic characterization of fas-associated phosphatase-1 as a putative tumor suppressor gene on chromosome 4q21.3 in hepatocellular carcinoma.
    Yeh SH; Wu DC; Tsai CY; Kuo TJ; Yu WC; Chang YS; Chen CL; Chang CF; Chen DS; Chen PJ
    Clin Cancer Res; 2006 Feb; 12(4):1097-108. PubMed ID: 16489062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Etodolac, a selective cyclo-oxygenase-2 inhibitor, enhances carboplatin-induced apoptosis of human tongue carcinoma cells by down-regulation of FAP-1 expression.
    Mishima K; Nariai Y; Yoshimura Y
    Oral Oncol; 2005 Jan; 41(1):77-81. PubMed ID: 15598589
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
    Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
    Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.